PH-

online

SustainabilityReport2024:

aGuideto

Growinga

GreenerIndustry

CPHI·.···

online

Con

tents

0

7

1

0

17

2

6

3

5

4

7

55

59

63

64

65

67

Introduction

Chapterone:Whatdidwelearnfrom2023

andwherearewenow?

Chaptertwo:Wranglingwithregulation

Chapterthree:Investinginsustainability

Chapterfour:Whatcanemerging

marketsbringtothesustainabilitytable?

Chapterfive:We’realllivingina

materialworld

Chaptersix:Collaborativeaction

throughpartnerships

Chapterseven:Attheheartof

sustainablepharma

Conclusion

Resources

References

Contributors

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry2

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry3

--

ContentsCPHi-ir

online

Introduction

The2024CPHISustainabilityReport

exploressustainableinitiatives,

innovationandthebiggestchallenges

facingthepharmaceuticalindustry,

layingthegroundworkforunderstanding

theimpactofthepharmaindustryon

climatechangeandthecommunitiesit

serves.Itasksthequestion–howcanwe

bringaboutactionablechangeforour

industryin2024andbeyond?

Bydrawingoninsightfromexpertsfrom

acrossthesupplychain,thegoalof

thisreportistodevelopunderstanding

andigniteaction,bringingmorein-

depthcritiquetocertainaspectsofthe

fieldandhelpingtoideatesolutionsfor

pharmacompaniesastheymapouta

greenerfuture.

Chapterone:Whatdid

welearnfrom2023and

wherearewenow?

Achallengewehavewithsustainability

isshowingmeasurablechange.This

chaptercoverssomeofthekeytopics

discussedinthe2023Sustainability

Report,fromScope1,2,and3emissions,

towastereductionandtheroleof

technologythroughoutthesupply

chain.Wequantifytheemissionsfrom

theindustryanddeterminewhether

thoseinvolvedareontracktomeettheir

sustainabletargets.

Chaptertwo:Wrangling

withregulation

Regulationsurroundingsustainable

actionsisnotanewconceptacross

globalindustries,howeveritseemstobe

forPharma.Duetothenatureofthefield,

humanhealthandsafetyarealways

thepriority,asitshouldbe,whichhas

ledtohesitancytochangehowsome

thingsintheindustryaredealtwithas

itwouldmeanrepeatingmorerounds

ofrigoroustesting.Thecallnowisto

pushonwiththesechangesaspeople

cometorealisethatsustainabilityis

intrinsicallylinkedtohumanhealth.This

chaptercoversincominglegislation,and

thecollaborativeactionrequired-that

whichcannotbetackledjustbeindividual

pharmaceuticalconglomerates.

Chapterthree:Investing

insustainability

Sustainabilityisapriorityformany

companiesnow,buttheshiftsatthe

coreofthebusinesstoachievegrowth

inthisareaneedtobeinvestedintobe

successful,andtokeepcompaniesas

fieldleaders.Thischaptercoverswhy

it’simportantforcompaniestoinvest

insustainability,inallaspectsoftheir

business,andhowbesttodothis.

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry4

--

ContentsCPHi-ir

online

Chapterfour:What

canemerging

marketsbringtothe

sustainabilitytable?

Emergingmarketsinpharmaceuticals

arehotbedsforinnovationandgrowth

intheindustry,pushingtheboundaries

inseveralaspects.Thischapterdelves

intohowmarketsinTheMiddleEast,

India,andChinaareworkingtowards

sustainablegoals.

Chapterfive:We’reall

livinginamaterialworld

Materiality-thesourcinganddeveloping

ofsustainablematerialsthatcanbe

usedacrosstheentireindustry,toreduce

waste,energyconsumption,emissions,

andultimatelyreduceclimatechange.

Thischapterfocusesonplasticuse

andchemistryapplicationsacross

pharmaceuticalsandhealthcare,

presentingsolutionsandalternatives

thatcanbeincorporatedintoregular

processesinamoreimmediate

timeframe.

Chaptersix:

Collaborativeaction

throughpartnerships

Partnershipsandcollaborationsarethe

keytosuccessincreatingagreener

future.Thisdoesn’tjustmeanwith

otherindustryleaderswhoarealready

pavingthewayandsettingbiggoals.

Partnershipsonamorecellularlevel

withinpharmabusinesses,thesuppliers,

contractors,manufacturers,distributors,

allplayersinvolvedinthevalue

chainmustcontributetosustainable

standards.Thischapteroffersadviceon

howtofacilitatestrongpartnershipsthat

dojustthat.

Chapterseven:Atthe

heartofsustainable

pharma

AtCPHIwewanttoplaymoreofarolein

assistingcompaniesreachsustainable

targets.Ourowneventsareworking

todecreaseourcarbonfootprintwith

sustainablematerials,reusingmaterials

yearonyear,andencouragingexhibitors

tobemoreeco-consciousthroughour

BetterStandsinitiative.

CPHI·.···

online

Foreword

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

CPHI·.···

online

Foreword

WelcometotheannualSustainabilityReportforthe

PharmaindustrybyCPHI,atestamenttoourcollectivecommitmenttofosteringahealthier,moresustainablefutureforbothourindustryandtheplanet.

AstheSustainabilityDirectoroftheCPHIportfolioofglobalPharmaevents,itgivesmegreatpleasuretopresentthis

comprehensiveoverviewofthestridestheindustryhasmadeinsustainabilityoverthepastyear.Inthesepages,you’llfindareflectionofourindustry’sdedicationtonotonlymeetingtheneedsofpatientsbutalsotostewardingtheresourcesandecosystemsuponwhichourcollectivewell-beingdepends.

Sustainabilityisnotmerelyabuzzwordforus;it’sa

guidingprincipledeeplyembeddedinallouractions.

Weunderstandthatthepursuitofsustainabilityisnotasolitaryjourneybutratheracollaborativeendeavourthatnecessitatesdialogue,cooperation,andsharedlearning.

AtCPHIwe’vemadeitaprioritytoengagewithasmany

colleaguesandstakeholdersfromthepharmaindustryaspossible,facilitatingconversationsthatsparkinnovationanddrivepositivechange.

Intheseconversations,we’vewitnessedagrowing

awarenessoftheinterconnectednessbetweenourindustry’sactivitiesandtheirbroadersocietalandenvironmental

impacts.Fromreducingcarbonemissionsandwaste

generationtopromotingethicalsupplychainsandequitable

accesstohealthcare,thepharmaindustryisembracingitsroleasacatalystforsustainabledevelopment.

Yet,wealsorecognisethatourjourneytowards

sustainabilityisongoingandmultifaceted.Whilewe

celebrateourachievements,weremainsteadfastinourcommitmenttocontinuousimprovement.Bysharingoursuccesses,challenges,andlessonslearned,wenotonlyholdourselvesaccountablebutalsoinspireotherstojoinusinourmissiontocreateaworldthatishealthier,moreequitable,andmoreresilientforgenerationstocome.

Asyoudelveintothisreport,Iencourageyoutoreflecton

thecollectiveimpactofoureffortsandtoconsiderhowwecanfurtherleverageourstrengthsandresourcestoaddressthepressingsustainabilitychallengesfacingourindustry

andourplanet.Together,wehavethepowertocreateandeffectmeaningfulchange–onestep,oneinnovation,andonepartnershipatatime.

ThankyouforyourcontinuedpartnershipinmakingthePharmaindustry–andtheworld–abetterandhealthierplace,everyday.

SilviaForroova

Director–Partnerships&Sustainability,InformaMarkets

6

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

PHl"

online

Introduction

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

7

Introduction

Creatingamoresustainablepharmaceuticalindustryisachallengingandongoingprocess,asitisacrossmanyothersectors.ThissustainabilityreportfromCPHIOnlineaimstoseehowfarwe’vecomeinrecentyears,buildingonthetopicscoveredinourreportin2023onthesupplyandvaluechain,andhowdifferentkindsofemissions

areinvolvedateverystage,andtheirimpactontheenvironment.

Thisreportlookstotaketheselessonsonestepfurther.

Nowthatwehaveabettergroundinginsustainability

inthepharmaceuticalworld,wecantakeaction.There

aremanyinitiatives,acrosshealthcareandbeyond,to

encourageandassistplayersintheirrespectivefields

inimprovingthemselvesandtheirbusinessmodelsin

respecttotheenvironmentandthepeopleitaffects.Inthepharmaceuticalindustrythisextendstomanydifferent

aspects,withmanyavenuestolookatanddevelop.This

canalsoberelativelyoverwhelming,makingithardtoknowwheretostart.

Thereportwillgointodetailonsomeofthemostdiscussedtopicsinthecurrentpharmasustainabilityclimate.Itwill

givecasestudiesofprogrammesandprocessesthat

canbeputinplace,providesolutions,andgivemore

informationoninitiatives,networks,andframeworksthatwouldbebeneficialtobeinvolvedin,dependingonthespecificneedsoftheplayer.

8

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

CPHI·.···

online

Thefollowingincludesinsightsfromsomeofthemost

forward-thinkingindustryleaders.Hearfromorganisations

whousetheirspecificareaofexpertisetopavetheway

orgiveguidanceonsustainablesolutions,withaview

toachievableoutcomesthatwilllimittheimpactofthe

pharmaceuticalandhealthcareindustryontheenvironment.

ExpertsfromthePSCI,BioPhorum,andAnthesisamong

otherscommentontheESGgoalscompaniesputinplace,onhowtodevelopasustainableworkingandofferingofacompany,andhowthisisinfluencedbyregulationandtheuseofpartnerships.

Fieldleadersinpackagingandmaterialityfrom

Nelipak

HealthcarePackaging

and

P?ppelmannFAMACPharma-

Medical

addtheirexpertiseandspecificcasestudieson

theinnovationsinsourcing,materials,andrecyclabilityin

pharma,withakeenfocusonplastics.

Wealsotakealookatthemovementsmadebyemergingmarkets,seeinghowgovernmentsandcompaniesare

takingtheinitiativetousetheuniqueopportunitiesthattheirregionsoffer.

Furtherinsightsinregulationareprovided,aswellas

lookingatthefinancialaspectofgreensolutionsandgreensupplychainsintheindustry,andwhatthiscanmeanfor

companiesofallstagesandsizes.

Finally,thereportofferssomeintrospectionfromCPHI.Howdowe,asaneventscompanyinpharma,contribute,whatwedotomitigateourimpact,andhowcanwecontinuetoimprove,aswellasprovidingapracticalplatformtoenableplayersacrosstheindustrytocollaborateandimprove.

9

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

CPHl"

online

Chapterone:

Whatdidwelearn

10

from2023and

wherearewenow?

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

Chapterone:

Whatdidwelearnfrom2023and

wherearewenow?

Inthe2023SustainabilityTrendReport,somekey

themesemergedrevolvingaroundScope3emissions,

collaboration,regulation,andtheimportanceofsharingbestpractices.Scope3emissionsweredeterminedtobethemostharmfultotheenvironmentatthispointintimeduetotheirindirectnature,whichhasledtothequestionofwhoisculpable.Thismeanslittleactionhasbeen

takentoactuallymitigatetheseemissions.Ourexperts

wantedtoseemorereportingofScope3emissionsandmorecompaniestakingresponsibilityfortheseemissionsthroughouttheirsupplychains.Whatwehaveseenisa

definiteincreaseinawarenessofScope3emissionsandmoreeffortstoimprovereporting.

11

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

CPHI·.···

online

Manycompaniesstilldonotreportallemissions

comprehensively,buttheydoreportthemtovaryingdegrees,whichisanimprovementonpreviousyears.

It’shardtodefinitivelystatewhetherregulationsand

legislaturehasimprovedgloballyinaconclusivesense

inregardstolimitingthepharmaceuticalindustry’s

environmentalimpact.However,therehavebeensignificantstepstakenbysomecountriesandgoverningbodies.

NicHunt,theGlobalHeadofSustainabilityatNelipakHealthcarePackagingstated:

“Morefocusonsustainabilitystrategyhasledtoreducedfootprints,morecircular

designs,greaterfocusonresilience,ethics,labourandhumanrights,andincreased

actionstoproveprogressthrough

credentialingandcompliance.Capital

flowsintoadvancedrecyclingandother

innovationiscreatingnewoptionsatscaleandincreasedawarenessoflegislative

changeiscontributingtoalignedcollaboration.”

TheGermanSupplyChainDueDiligenceActisaprime

exampleofrecentlegislativechange,whichcameinto

effectfromJanuary2023,theActobligescompaniesthat

areheadquarteredinGermanytocomplywithacertain

setofmeasurestoensureenvironmentalandhumanrightsstandardsaremet.

Alsointhepastyear,wehaveseengreater

acknowledgementofthehealthcareindustryashaving

alargeimpactonclimatechange,whichalsooffersan

opportunityforimprovement.AtCOP28heldinDubaiin

2023,forthefirsttimeadeclarationonthefieldwassigned

–the

COP28UAEDeclarationonClimateandHealth

–

by132countries,provingtobeoneofthemostpopular

declarationsfromtheevent[1].

Thedeclarationstatesthat:‘Climatechangeisthegreatestthreattohumanlives,health,livelihoods,andwell-beinginthe21stcenturyandamplifiespeaceandsecurityissues’[1].

Onamoremolecularscale,whenaskedaboutthe

awarenessofcompaniesregardingScope3emissionsandtheirimpactonclimatechange,expertsstatethattheyareseeingmorestepstakenbyindividualcompanies,Nicola

Coles,BioPhorumsaid:

12

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

CPHI·.···

online

“Yesweareseeinglicenseholdersand

supplierscascadingtargetsandeducationthroughtheirsupplychain.”

MichaelGierfromP?ppelmannFAMACPharma-Medicaladded:

“Inouropinion,theindustryhasalreadyrealisedthis.Whatisneedednowis

consistentactionacrossallstagesofthevaluechain.WeatP?ppelmann

arecommittedtoreduceourabsolutegreenhousegasemissionsby2030

comparedto2021by50%inScope1and2and25%inScope3.”

Suchcommitmentsastheabovearebecomingmore

andmoreingrainedintothecultureandfutureplanningofcompaniesthroughoutthesupplychain,theresultsofwhichmaystillneedsomeyearstobeseen.

WhenCPHIsurveyedtheattendeesattheCPHIevents,

respondentscommentedonhowcommittedtheythoughttheirowncompaniesweretosustainability.

Figure1:Source:SustainabilityinPharmaInfographic[2]

13

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

CPHI·.···

online

TheChairofthePSCI,DeirdreOReilly,whoisalsoSeniorDirectorofGlobalEHSSupplierOperationsandBusinessDevelopment,Viatris,explainedhowtheyarehoping

tosupportandencouragebusinessestoachievetheirenvironmentalgoals:

“AddressingandreducingScope3

emissionsisahugeundertakingforthe

pharmaandhealthcareindustryandone

thatrequiresinnovationandcollaboration.Decarbonisingthevaluechaincan’tbe

achievedalone,andwe’veseenasurge

inpartnershipapproachestothisthroughtheSustainableMarketsInitiativeand

others.ThroughthePSCI,we’reworkingtosupportourmemberswithpracticaltoolstheycansharewiththeirsupplierslikeourDecarbonisationPathway,whichclearly

laysoutthebeginnertoadvancedsteps

companiescantakeontheroadtonetzero.Thechallengeremainsbutisonethatthe

industrytakesseriously.”

The

PSCI

supportstheworkof

SchneiderElectric

andtheir

Energizeprogramme,expertLilyProomfromSchneideralso

addsherconsiderationsonhowfarthepharmaceutical

industryhascome.

ThepharmaceuticalindustrydoesseemtobeactivelyreckoningwiththeneedtoaddressScope3emissions.

SchneiderElectricmanagestheEnergizeprogramme,acollaborationof20companiesthatareworkingtogethertoacceleratedecarbonisationinthepharmaceutical

andhealthcaresupplychainbyprovidingrenewable

electricityeducationandpurchasingsupporttopharmaandhealthcaresuppliers.Wehaveseenthenumberof

companiessponsoringthisprogrammewhichmeansthattheyareactivelyworkingtoengagetheirsupplierstolearnaboutandpurchaserenewableenergycontinuetogrowinthepastyear.MoreEnergizesponsorsare

holdingsupplier-specificeventsaroundrenewable

energyandemissionsreductions,creatingsupplychaindecarbonisationtargetsandplanstomeetthosetargets,andsettingexpectationsforsuppliersaroundrenewableelectricityadoption.

14

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

CPHI·.···

online

“Manycompanieshavesupplychainemissionsreductiontargets,ortargetsfortheirowncompanythatrelyupon

supplychaindecarbonisation,thatwillcomeduein2030(orevensooner).Asthesedeadlinesapproach,Iexpect

thatwe’llseemoreandmoreactiontakentoengage

suppliersandsupportthemtoreducetheiremissionswithprogrammeslikeEnergize.”

Theproofofthisactionisincreasinglyvisibleinthesteps

thatplayersinthepharmaceuticalindustryhavebeen

taking.Thesecanbeonamoreindividualscale,whichwe

canseeexamplesoffrom

P?ppelmannFAMACPharma-

Medical,

whohaveimplementedseveralmeasures:

1.ImplementationoftheinitiativeP?PPELMANNblue?,

tomakeproductsandprocessesasecologicalas

possibleandachieveclosedmaterialloops,byworkingwithallpartners.

2.ProductdevelopmentaccordingtoECO-design:wheretheydesignsustainablepackagingthatstillmeetsthecriteriaforsafety,machinecompatibility,andhygiene.

3.Aclimatestrategyinlinewiththe1.5°CtargetoftheParisAgreement–nowconfirmedbytheScience

BasedTargetsinitiative.

GierlistedthewaysinwhichtheircompanytacklesScope1,2and3emissions:

“WeatP?ppelmannachieveloweremissionsinScope1and2through:

?MoreLEDlighting(inimplementation)

?Morephotovoltaiccellsontheroofs(inimplementation)

?Moree-mobility(inimplementation)

WeachieveloweremissionsinScope3byimplementingtruecirculareconomy.Ourlargestleveristhecircular

economy.Wealreadyuse42%post-consumerrecyclatesacrossallbusinessareasatP?ppelmann.Wherethisisnotpossible,wefocusoneco-designtoachievesavingsin

otherways:

?Post-consumerrecyclatematerial(PCR-material)forprotectiveelements

?PCR-materialintheHalterSoundgenerator

?PCR-materialforreactionvessels.”

15

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter1:Whatdidwelearnfrom2023andwherearewenow?

CPHI·.···

online

Proomdetailshowworkingtogetherhasprovento

beextremelysuccessfulwhenitcomestoadvancingdecarbonisationacrosstheindustry:

“Industry-wideprogrammestoengagesupplychainssuchasEnergizecanbehighlyimpactful;oftentimessuppliers

intheprogrammesupplytomultiplesponsors,andsothe

messagetheyreceivefromsponsorstoparticipateinthe

programmeandpursuerenewablesisamplified.Industry-wideprogrammesalsocreatesimplicityforsuppliers;ratherthanbeingaskedtoparticipateintendifferentrenewable

electricityprogrammes,suppliersthatsupplytotenof

thesponsorsareaskedtoparticipateinonecommon

programme.Finally,aprogrammelikeEnergizethathas

collectiveindustrysupportbehinditisinastrongerpositiontoeffectivelymessageexternallyabouttheneedfor

supplychaindecarbonisationinthepharmaceuticalandhealthcareindustry,anddriveengagement.”

SpeakingtothespecificadvantagesoftheEnergizeprogramme,Proomadded:

“OneofEnergize’smostuniquebenefitsisthatitoffers

participatingsupplierstheopportunitytopursuea‘multi-buyerpowerpurchaseagreement’,whereinsupplierspooltheirelectricitydemandinaparticularmarkettopursueapowerpurchaseagreementasagroup.Thisdrasticallyreducestheelectricitydemandthatasuppliermusthave

inamarkettopursueapowerpurchaseagreementandcreatesopportunityforsharingofbestpracticesbetweensuppliers,whichenablescompaniestopursuepower

purchaseagreementswhowouldnothavebeenable

tootherwise.Thisuniquestructuregivessuppliers–whomaynototherwisehavebeenabletopursuethistypeofrenewableelectricitypurchasing–accesstolong-term,environmentallyimpactfulrenewableelectricitysources.”

Renewableenergyhascometotheforeinthelastyearasakeypartoftheindustry’sactionplantoreducecarbon

emissions,severallargecompanieshavepledgedtomakethemovetorenewableenergy,evenincountrieswherethispresentsseveralchallenges,suchasinChina[3].

Colesalsoconfirmedtheescalatingeffortsofindustryleaders:

“Severalconsortiahavecometogethertoimprove

comparabilityofdatabydevelopingharmonised

approachestoLifeCycleAnalysisandProductCarbon

Footprintforpharmaceuticalproductsandtheirsupplies.”

Dataisattheheartofmanyofthesemeasures,by

understandingtheimpactsasitcomesdowntotherawfactsofthematter,consortiaareabletousethesefigurestomonitorandseesignificantimprovementsasinitiativescontinueandinvariablygaingroundinreversingharmfulprocesses.

16

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

PHl"

online

Chaptertwo:

Wranglingwith

regulation

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

17

CPHI·.···

online

Chapter2:Wranglingwithregulation

Chaptertwo:

Wranglingwithregulation

Manyconversationsoverthepastyearhavebeen

centredaroundregulationandreportinginrelationto

environmentalimpact,specificallyabouttheneedfor

furtherregulationthanisalreadyinplace[2].Regulation

aroundgoals,whethercompaniesshouldbefinediflimitsareexceeded,andotherlegislativetacticssuchaslife

cycleassessmentsneedtobemadecompulsoryandimportantly,visibletothepublicaswellasmorevisiblein-industry,toincreasetransparencyofoperationsandaccountability.

Itisessentialstakeholdersatalllevels,especiallyin

seniormanagementtounderstandtheimportance

ofsustainability[4].ThiscanbethroughESGreporting

strategiestoinformtheindustryonhowcompaniesaremanagingthesestrategiesandfuture-proofingthem.

18

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter2:Wranglingwithregulation

CPHI·.···

online

Speakingtowhetherregulationisthekeywaytoencouragefurtheradherencetosustainabilityvaluesandgoals,and

impressuponplayersintheindustrytheimportanceofprotectingtheenvironmentasacriticalhumanhealthfactor,Colesstated:

“ThebiggestchallengeIseeforpharmaisthatCMCregulationhasstifledinnovationforsolongthatwehavelearnednot

tochange,improveoradapt.Forusto

achievethetargetswehavesetandfor

ustoreduceourenvironmentalimpactasasector,wemustworkwithhealthcare

agenciestoapproachchangedifferently,sothatsustainabilityisconsideredafactoralongsidesafetyandquality.”

Anotherchallengesurroundinglegislationistheglobal

applicabilityofanyregulations.Regionsallovertheworldexperiencedifferentprioritieswhenitcomestothehealthandpharmaceuticalindustry,anddifferentscenariosthatrequiretailoredplanninginthisrespect.Huntcommentedonthis:

“Universalregulationalwayssimplifies

understanding.Thatsaidcomplyinglocallymayaddcomplexity,notreduceit.While

thereisnoconsolidatedlegislationtoday,alignmenttowardsestablishpolestars

suchasUNSDGisgraduallybringing

regionstothepointofinter-operability,whichmaybethebestsolution,givenfullharmonisationistimeconsuming.”

19

SustainabilityReport2024:aGuidetoGrowingaGreenerIndustry

Chapter2:Wranglingwithregulation

CPHI·.···

online

Statusupdate:Wherearewenow?

Currently,policycoverageacrosssectorsisuneven.

Broaderpoliciesimplementedattheendof2020are

projectedtoresultinhigherglobalgreenhousegas

emissionsin2030thanemissionspredictedbyNationally

DeterminedContributions[5].Thisimpliestherecouldbean‘implementationgap’.Ifnothinghereisamendedorbuilt

upon,wecouldbeleftwithaglobalincreaseintemperatureof2.2to3.5°Cby2100[5].

In2019theEuropeanCommissioncreatedastrategy

called

TheEuropeanGreenDeal

.TheGreenDealeffectively

roadmapstheplanonthewaytothecontinentbecoming

thefirstclimateneutralcontinentby2050,creatingamore

resource-efficientandsustainableeconomy[6].Although

notstrictlylimitedtothehealthcaresector,thedealhas

beenupdatedtoincludelessonslearnedfromthe

COVID-19pandemicinutilisinggreentechnologyan